Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank36
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-240.13%
↑ 89% vs avg
Percentile
P36
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-2245.00%
Historical baseline
PeriodValueYoY Change
2025-240.13%+94.9%
2024-4670.14%+65.0%
2023-13351.79%-270.4%
2022-3604.66%-6215.1%
202158.95%+109.2%
2020-642.26%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-